Fuchs CS - Search Results

1

Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer.

Abrams TA, Brightly R, Mao J, Kirkner G, Meyerhardt JA, Schrag D, Fuchs CS. Abrams TA, et al. Among authors: fuchs cs. J Clin Oncol. 2011 Aug 20;29(24):3255-62. doi: 10.1200/JCO.2011.35.0058. Epub 2011 Jul 18. J Clin Oncol. 2011. PMID: 21768462

2

Adjuvant chemotherapy for colon and rectal cancer.

Fuchs CS, Mayer RJ. Fuchs CS, et al. Semin Oncol. 1995 Oct;22(5):472-87. Semin Oncol. 1995. PMID: 7570058 Review. No abstract available.

3

Chemotherapy options for gastric cancer.

Meyerhardt JA, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. Semin Radiat Oncol. 2002 Apr;12(2):176-86. doi: 10.1053/srao.2002.30823. Semin Radiat Oncol. 2002. PMID: 11979419 Review.

4

Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.

McCollum AD, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. McCollum AD, et al. Among authors: fuchs cs. J Natl Cancer Inst. 2002 Aug 7;94(15):1160-7. doi: 10.1093/jnci/94.15.1160. J Natl Cancer Inst. 2002. PMID: 12165641 Clinical Trial.

5

Impact of diabetes mellitus on outcomes in patients with colon cancer.

Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. J Clin Oncol. 2003 Feb 1;21(3):433-40. doi: 10.1200/JCO.2003.07.125. J Clin Oncol. 2003. PMID: 12560431 Clinical Trial.

6

Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer.

Fuchs CS, Moore MR, Harker G, Villa L, Rinaldi D, Hecht JR. Fuchs CS, et al. J Clin Oncol. 2003 Mar 1;21(5):807-14. doi: 10.1200/JCO.2003.08.058. J Clin Oncol. 2003. PMID: 12610178 Clinical Trial.

7

Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.

Ayanian JZ, Zaslavsky AM, Fuchs CS, Guadagnoli E, Creech CM, Cress RD, O'Connor LC, West DW, Allen ME, Wolf RE, Wright WE. Ayanian JZ, et al. Among authors: fuchs cs. J Clin Oncol. 2003 Apr 1;21(7):1293-300. doi: 10.1200/JCO.2003.06.178. J Clin Oncol. 2003. PMID: 12663717

8

Adjuvant therapy in gastric cancer: can we prevent recurrences?

Meyerhardt JA, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. Oncology (Williston Park). 2003 May;17(5):714-21, 728; discussion 728-9, 732-3. Oncology (Williston Park). 2003. PMID: 12800796 Free article. Review.

9

Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.

Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB 3rd, Macdonald JS, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. Cancer. 2003 Aug 1;98(3):484-95. doi: 10.1002/cncr.11544. Cancer. 2003. PMID: 12879464 Free article. Clinical Trial.

10

A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.

Ryan DP, Clark JW, Kulke MH, Fuchs CS, Earle CC, Enzinger PC, Stuart K, Catarius KJ, Winkelmann J, Mayer RJ. Ryan DP, et al. Among authors: fuchs cs. Cancer Invest. 2003;21(4):505-11. doi: 10.1081/cnv-120022359. Cancer Invest. 2003. PMID: 14533439 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

751 results

Search Page

Filters